Biomaterials as vectors for the delivery of CRISPR–Cas9

The emergence of the CRISPR–Cas9 gene editing system has generated considerable hope and excitement in the field of gene therapy and the larger scientific community. Recently, biomaterials have become an attractive option for the delivery of Cas9 due to their remarkable versatility.